PERSISTENCE OF USTEKINUMAB (UST) OR TNF INHIBITOR (TNFI) TREATMENT IN PSORIATIC ARTHRITIS (PSA): INSIGHTS FROM THE LARGE, PROSPECTIVE, MULTINATIONAL, REAL-WORLD PSABIO COHORT

被引：2
|
作者：
Gossec, L. [1 ]
Siebert, S. [2 ]
Bergmans, P. [3 ]
De Vlam, K. [4 ]
Gremese, E. [5 ]
Joven-Ibanez, B. [6 ]
Korotaeva, T. [7 ]
Noel, W. [8 ]
Nurmohamed, M. T. [9 ,10 ]
Sfikakis, P. [11 ]
Theander, E. [12 ]
Smolen, J. S. [13 ]
机构：
[1] Sorbonne Univ, Paris, France
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Janssen, Breda, Netherlands
[4] Univ Hosp, Leuven, Belgium
[5] Univ Cattolica Sacro Cuore, Fdn Policlin Gemelli IRCCS, Rome, Italy
[6] Hosp 12 Octubre, Madrid, Spain
[7] Nasonova Res Inst Rheumatol, Moscow, Russia
[8] Janssen, Brussels, Belgium
[9] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[10] Reade, Amsterdam, Netherlands
[11] Univ Athens, Med Sch, Athens, Greece
[12] Janssen, Solna, Sweden
[13] Med Univ Vienna, Vienna, Austria
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.2127
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0398
引用
收藏
页码：1145 / 1146
页数：2
相关论文
共 47 条
  • [1] COMPARATIVE EFFECTIVENESS OF USTEKINUMAB (UST) AND TNF INHIBITORS (TNFI) IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA) IN THE REAL-WORLD, MULTINATIONAL PSABIO STUDY: 12-MONTH FOLLOW-UP
    Smolen, J. S.
    Siebert, S.
    Korotaeva, T.
    Bergmans, P.
    De Vlam, K.
    Gremese, E.
    Joven-Ibanez, B.
    Noel, W.
    Nurmohamed, M. T.
    Sfikakis, P.
    Theander, E.
    Gossec, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 774 - 775
  • [2] SIX-MONTH TREATMENT RESULTS FOR USTEKINUMAB (UST) AND TNF INHIBITORS (TNFI) IN PSORIATIC ARTHRITIS (PsA) IN EUROPE (PsABio-STUDY)
    Smolen, J. S.
    Bergmans, P.
    Bondareva, I
    de Vlam, K.
    Gremese, E.
    Joven-Ibanez, B.
    Korotaeva, T., V
    Nurmohamed, M. T.
    Sfikakis, P. P.
    Siebert, S.
    Smirnov, P.
    Theander, E.
    D'Abrosca, V
    Gossec, L.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 729 - 729
  • [3] EFFECT OF SEX ON DISEASE CHARACTERISTICS AND DISEASE IMPACT IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA): INSIGHTS FROM THE REAL-WORLD, OBSERVATIONAL MULTINATIONAL PSABIO COHORT
    Nurmohamed, M. T.
    Van der Horst-Bruinsma, I.
    Van Kuijk, A. W.
    Siebert, S.
    Bergmans, P.
    De Vlam, K.
    Gremese, E.
    Joven-Ibanez, B.
    Korotaeva, T.
    Noel, W.
    Sfikakis, P.
    Theander, E.
    Smolen, J. S.
    Gossec, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1167 - 1169
  • [4] USTEKINUMAB AND TNFI SAFETY DATA AND CARDIOVAS-CULAR EVENTS IN PSORIATIC ARTHRITIS: RESULTS FROM THE REAL-WORLD PSABIO STUDY
    Gossec, L.
    Bergmans, P.
    Noel, W.
    Siebert, S.
    Theander, E.
    Smolen, J. S.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1169 - 1170
  • [5] PERSISTENCE OF SECUKINUMAB AND USTEKINUMAB IN PSORIATIC ARTHRITIS: A REAL-WORLD MULTICENTRIC COHORT OF 409 PATIENTS
    Letarouilly, J. G.
    Flachaire, B.
    Labadie, C.
    Cohen, N.
    Kyheng, M.
    Sellam, J.
    Richette, P.
    Dieude, P.
    Claudepierre, P.
    Fautrel, B.
    Houvenagel, E.
    Nguyen, C. D.
    Guyot, M. H.
    Segaud, N.
    Maury, F.
    Marguerie, L.
    Deprez, X.
    Salmon, J. H.
    Baudens, G.
    Richard, C. Miceli
    Gervais, E.
    Valckenaere, I. Chary
    Lafforgue, P.
    Loeuille, D.
    Richez, C.
    Pham, T.
    Flipo, R. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 765 - 765
  • [6] Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study
    Gossec, Laure
    Siebert, Stefan
    Bergmans, Paul
    de Vlam, Kurt
    Gremese, Elisa
    Joven-Ibanez, Beatriz
    Korotaeva, Tatiana, V
    Lavie, Frederic
    Noel, Wim
    Nurmohamed, Michael T.
    Sfikakis, Petros P.
    Sharaf, Mohamed
    Theander, Elke
    Smolen, Josef S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (04) : 496 - 506
  • [7] Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world study
    Laure Gossec
    Elke Theander
    Soumya D. Chakravarty
    Paul Bergmans
    Frederic Lavie
    Wim Noël
    Mohamed Sharaf
    Stefan Siebert
    Josef S. Smolen
    [J]. Arthritis Research & Therapy, 25
  • [8] Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world study
    Gossec, Laure
    Theander, Elke
    Chakravarty, Soumya D. D.
    Bergmans, Paul
    Lavie, Frederic
    Noel, Wim
    Sharaf, Mohamed
    Siebert, Stefan
    Smolen, Josef S. S.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [9] SIMILAR CLINICAL RESPONSES, SAFETY AND TREATMENT PERSISTENCE WITH USTEKINUMAB IN YOUNGER VS OLDER PATIENTS WITH PSORIATIC ARTHRITIS AT 12 MONTHS IN THE REAL-WORLD PSABIO STUDY
    Gossec, L.
    Theander, E.
    Chakravarty, S. D.
    Bergmans, P.
    Lin, I.
    Noel, W.
    Siebert, S.
    Smolen, J. S.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1169 - 1169
  • [10] Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio Study
    Gossec, Laure
    Siebert, Stefan
    Bergmans, Paul
    de Vlam, Kurt
    Gremese, Elisa
    Joven-Ibanez, Beatriz
    Korotaeva, Tatiana, V
    Lavie, Frederic
    Noel, Wim
    Nurmohamed, Michael T.
    Sfikakis, Petros P.
    Theander, Elke
    Smolen, Josef S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (06) : 823 - 830
12345